Offer - Urjas Oil for just ₹ 1 X
Respolite is a prescription drug, available for use as Syrup, Tablet. Bronchitis are some of its major therapeutic uses. The alternative uses of Respolite have also been explained below.
The right dosage of Respolite depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Respolite include Constipation, Heartburn, Nausea or vomiting. Besides the aforementioned side effects, there are other adverse effects of Respolite as well, which are listed below. Usually, these side effects of Respolite go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Respolite has a Severe effect for pregnant women and Severe effect on lactating mothers. It is important to know if Respolite has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Respolite related warnings section.
Respolite is not recommended if you suffer from certain medical conditions as it can have adverse effects. Gastrointestinal Bleeding are examples of such conditions.
Drug interactions for Respolite have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Respolite is safe while driving, and is is addictive in nature.
Respolite is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Geriatric |
|
Adult |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Respolite safe for pregnant women?
Pregnant women may get severe side effects after taking Respolite. If you are pregnant, do not take Respolite without a doctor's advice.
Is the use of Respolite safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Respolite. So it is adviced to consult the doctor before using it.
What is the effect of Respolite on the Kidneys?
Very few cases of side effects of Respolite on kidney have been reported.
What is the effect of Respolite on the Liver?
Respolite may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Respolite on the Heart?
Respolite may have mild side effects on the heart. Most people will never see any effect on the heart.
Respolite should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Respolite unless your doctor advises you to do so -
Is this Respolite habit forming or addictive?
No, there is no any evidence that Respolite is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Respolite will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Respolite should be used only after doctor's advice.
Is it able to treat mental disorders?
Respolite is unable to treat or cure mental disorders.
Interaction between Food and Respolite
There is no information on the effects of taking Respolite with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Respolite
It is difficult to say anything about the effect of Respolite and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219